Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1090800.RARzTjAgiq0uj4aR5Ccb5TLecVf-qzJM0ALmJzfkBYqTo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1090800.RARzTjAgiq0uj4aR5Ccb5TLecVf-qzJM0ALmJzfkBYqTo130_assertion type Assertion NP1090800.RARzTjAgiq0uj4aR5Ccb5TLecVf-qzJM0ALmJzfkBYqTo130_head.
- NP1090800.RARzTjAgiq0uj4aR5Ccb5TLecVf-qzJM0ALmJzfkBYqTo130_assertion description "[This approach has been successfully employed in the clinical approval of crizotinib for the treatment of ALK-rearranged non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1090800.RARzTjAgiq0uj4aR5Ccb5TLecVf-qzJM0ALmJzfkBYqTo130_provenance.
- NP1090800.RARzTjAgiq0uj4aR5Ccb5TLecVf-qzJM0ALmJzfkBYqTo130_assertion evidence source_evidence_literature NP1090800.RARzTjAgiq0uj4aR5Ccb5TLecVf-qzJM0ALmJzfkBYqTo130_provenance.
- NP1090800.RARzTjAgiq0uj4aR5Ccb5TLecVf-qzJM0ALmJzfkBYqTo130_assertion SIO_000772 23819947 NP1090800.RARzTjAgiq0uj4aR5Ccb5TLecVf-qzJM0ALmJzfkBYqTo130_provenance.
- NP1090800.RARzTjAgiq0uj4aR5Ccb5TLecVf-qzJM0ALmJzfkBYqTo130_assertion wasDerivedFrom befree-2016 NP1090800.RARzTjAgiq0uj4aR5Ccb5TLecVf-qzJM0ALmJzfkBYqTo130_provenance.
- NP1090800.RARzTjAgiq0uj4aR5Ccb5TLecVf-qzJM0ALmJzfkBYqTo130_assertion wasGeneratedBy ECO_0000203 NP1090800.RARzTjAgiq0uj4aR5Ccb5TLecVf-qzJM0ALmJzfkBYqTo130_provenance.